Iterum Therapeutics Plc (NASDAQ: ITRM) reported Q2 EPS of ($0.95), $0.23 worse than the analyst estimate of ($0.72).

For earnings history and earnings-related data on Iterum Therapeutics Plc (ITRM) click here.